$5.4M Wellcome Trust grant for blood disorder therapeutic development

CCS researchers involved in understanding the biology
underpinning the therapeutic development.
L-R: Dr Fiona Brown, Dr Stefan Sonderegger, A/Prof David
Curtis, Prof Stephen Jane, Ms Loretta Cerutti.
Absent: Dr Emma Toulmin

$5.4 million funding will allow Monash researchers to develop novel approaches to treat major blood disorders, by switching on a form of haemoglobin normally only utilised by babies before birth.